MYC and acute lymphoblastic leukemia: C‐Myc upregulation has been detected in human ALL via various mechanisms, for example, translocations t(8;14), t(8;22), and t(2;8), aberrant C‐Myc stability, prolonged C‐Myc protein half‐life, and activating mutations in NOTCH1.16